Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
47°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abvc Biopharma Inc
(NQ:
ABVC
)
0.6600
-0.0310 (-4.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abvc Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
November 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
November 15, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
October 27, 2023
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...
Via
Benzinga
What's Going On With ABVC Biopharma Stock Friday?
October 27, 2023
ABVC Biopharma Inc (NASDAQ: ABVC) shares are trading higher by 7% to $1.37 Friday morning. The stock surged by 300% and then retreated on Thursday following the company's announcement of a term sheet...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
Via
Benzinga
Crude Oil Down 2.5%; Mastercard Posts Upbeat Earnings
October 26, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded down 0.29% to 32,938.92 while the NASDAQ fell 1.33% to 12,650.31. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
October 26, 2023
Via
Benzinga
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 26, 2023
Gainers
Via
Benzinga
Dow Dips Over 100 Points; US GDP Growth Tops Expectations
October 26, 2023
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.36% to 32,918.38 while the NASDAQ fell 1.12% to 12,677.56. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed; Bristol Myers Posts Upbeat Earnings
October 26, 2023
U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What In The World Is Going On With ABVC BioPharma Stock?
October 26, 2023
ABVC Biopharma Inc (NASDAQ: ABVC) shares are trading higher by 309% to $3.48 Thursday morning after the company announced it entered into a term sheet to license the global rights of CNS drugs with the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 26, 2023
Via
Benzinga
ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million
October 26, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Intraday Session
October 23, 2023
Via
Benzinga
ABVC BioPharma Announces Completion of Subject Recruitment for Interim Analysis on ADHD Phase IIb Clinical Study
October 17, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
Via
Benzinga
ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)
October 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 19, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
Via
Benzinga
ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study
August 23, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Executes Cooperation Agreement for Strategic Investments
August 17, 2023
FREMONT, CA - (NewMediaWire) - August 17, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology,...
Via
NewMediaWire
ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement
August 10, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Corporate Update and CEO's Letter to Shareholders
August 07, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
August 05, 2023
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize...
Via
Talk Markets
ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration
August 03, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 01, 2023
Via
Benzinga
Gold Down 1.5%; ISM Manufacturing PMI Rises To 46.4 In July
August 01, 2023
U.S. stocks were mixed midway through trading, with the Nasdaq Composite falling around 45 points on Tuesday. The Dow traded up 0.06% to 35,581.83 while the NASDAQ fell 0.32% to 14,299.54. The S&P 500,...
Via
Benzinga
ABVC Biopharma (NASDAQ: ABVC) Inks Major Licensing Agreement with Xinnovation Therapeutics for ABV-1504 and ABV-1505
August 01, 2023
Landmark Licensing Deal for ABVC in China's Growing Healthcare Market ABVC Biopharma, Inc. (NASDAQ: ABVC), a pioneer in the development
Via
Spotlight Growth
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.